???pagination.result.count???
???pagination.result.page???
1
Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels. , Tammaro P., J Physiol. February 15, 2006; 571 (Pt 1): 3-14.
Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides. , Reimann F., J Physiol. February 15, 2003; 547 (Pt 1): 159-68.
The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/ SUR1 channel opener. , Dabrowski M., Diabetes. June 1, 2002; 51 (6): 1896-906.
Structural basis for the interference between nicorandil and sulfonylurea action. , Reimann F., Diabetes. October 1, 2001; 50 (10): 2253-9.
Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels. , Dabrowski M., Diabetologia. June 1, 2001; 44 (6): 747-56.
Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels. , Song DK., Br J Pharmacol. May 1, 2001; 133 (1): 193-9.
Effects of mitiglinide (S 21403) on Kir6.2/ SUR1, Kir6.2/ SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. , Reimann F., Br J Pharmacol. April 1, 2001; 132 (7): 1542-8.
Nucleotide modulation of pinacidil stimulation of the cloned K(ATP) channel Kir6.2/ SUR2A. , Gribble FM., Mol Pharmacol. June 1, 2000; 57 (6): 1256-61.
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. , D'hahan N., Proc Natl Acad Sci U S A. October 12, 1999; 96 (21): 12162-7.
Interaction of vanadate with the cloned beta cell K(ATP) channel. , Proks P., J Biol Chem. September 3, 1999; 274 (36): 25393-7.
Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide. , Gribble FM., Diabetologia. July 1, 1999; 42 (7): 845-8.
Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. , Gribble FM., Diabetes. September 1, 1998; 47 (9): 1412-8.